4
Changes in Ownership
Emergent BioSolutions Inc. Filed Acc 0001628280-25-040670
Director sold 7,086 shares at $8.87 ($62,853)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Zoon Kathryn C Director | 2025-08-15 | Sale 10b5-1 | −7,086 | $8.87 | $62,853 | 71,799 | D: show line 1 in the form |
| Open-market sales · 7,086 sh · avg $8.87 · $62,853 | |||||||
Loading xslF345X05/wk-form4_1755549206.xml…